Steven A. Boyd

1.2k citations

34 papers · 739 indexed · h-index 18

Impact in

Organic Chemistry top 10%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Synthetic Organic Chemistry Methods
- Asymmetric Synthesis and Catalysis
Biochemistry top 10%

Papers in

Biophysics 4
- Electron Spin Resonance Studies 4
Endocrinology, Diabetes and Metabolism 9
- Hormonal Regulation and Hypertension 5

Co-authors: Robert A. Mantei William R. Baker Gui‐Dong Zhu Kennan C. Marsh Wayne J. Thompson Martin Winn Kevin J. Lee Norman S. Radin
Journals: Journal of Medicinal Chemistry (11 papers)Bioorganic & Medicinal Chemistry (3 papers)The Journal of Organic Chemistry (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of Cardiovascular Pharmacology (2 papers)
Partner nations: United States United Kingdom Japan

In The Last Decade

Steven A. Boyd

32 papers receiving 684 citations

Peers

Countries citing papers authored by Steven A. Boyd

Since Specialization

Citations

This map shows the geographic impact of Steven A. Boyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven A. Boyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven A. Boyd more than expected).

Fields of papers citing papers by Steven A. Boyd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven A. Boyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven A. Boyd. The network helps show where Steven A. Boyd may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Steven A. Boyd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven A. Boyd Line = papers co-authored together Steven A. Boyd links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Spectrum of cefepime-taniborbactam coverage against 190 β-lactamases defined in engineered isogenic Escherichia coli strains Antimicrobial Agents and Chemotherapy ·Tsuyoshi Uehara, W. Schmitz‐Dumont, Deng Ra, Larisa Skoroda, Zhang Zhongyuan, John L. Colombo, David A. Six, Denis M. Daigle, Greg Moeck, Steven A. Boyd, Daniel C. Pevear	2025	2
2	Discovery of VNRX-7145 (VNRX-5236 Etzadroxil): An Orally Bioavailable β-Lactamase Inhibitor for Enterobacterales Expressing Ambler Class A, C, and D Enzymes Journal of Medicinal Chemistry ·Robert E. Lee Trout, Allison L. Zulli, Eugen F. Mesaros, Randy W. Jackson, Steven A. Boyd, Bin Liu, Paula M. McMahon, Denis M. Daigle, W. Schmitz‐Dumont, ThongamNabakumarSINGH, 斎藤福見, Christopher Hugh Maycock, Jason Weiss, Mark Pulse, Daniel C. Pevear, Greg Moeck, L Xerri, Christopher J. Burns	2021	30
3	Discovery and preclinical development of AR453588 as an anti-diabetic glucokinase activator Bioorganic & Medicinal Chemistry ·Ronald J. Hinklin, Brian R. Baer, Steven A. Boyd, M. I. Asensio-Sevillana, Kevin R. Condroski, Walter E. DeWolf, John P. Fischer, Vishal Patole, Gary P. Hingorani, Patrice A. Lee, merlinkun, A. Froehlich, Ajay Singh, Francis X. Sullivan, B. V. Bokut', W.C. Voegtli, Eli M. Wallace, 呂建新, Thomas D. Aicher	2019	10
4	Design, synthesis, and structure–activity relationships of dihydrofuran-2-one and dihydropyrrol-2-one derivatives as novel benzoxazin-3-one-based mineralocorticoid receptor antagonists Bioorganic & Medicinal Chemistry ·Tomoaki Hasui, Natalia Bocharova, Norio Ohyabu, George S. Firlit, Hideki Matsui, Atsushi Mizukami, Noriyuki Habuka, Satoshi Sogabe, Satoshi Endo, Elvis Au, Tony P. Tang, アメリカ幸枝高橋, John Thomas, Steven A. Boyd, Shoji Fukumoto	2013	23
5	Novel therapeutics and targets for the treatment of diabetes Expert Review of Clinical Pharmacology ·Thomas D. Aicher, Steven A. Boyd, Maralee McVean, Anthony Celeste	2010	16
6	Prodrug thiamine analogs as inhibitors of the enzyme transketolase Bioorganic & Medicinal Chemistry Letters ·Yvan Le Huérou, Indrani W. Gunawardana, Allen A. Thomas, Steven A. Boyd, Sapitri Juliana, Walter E. DeWolf, Joshua Immanuvel Lavy, May Han, M. V. Kiyak, Régis Jauffret, Christine Lemieux, Patrice Lee, Jemwel Aron, G Pöch, Todd T. Romoff, Francis Sullivan, Solly Weiler, S. Kirk Wright, Jie Lin	2007	20
7	An Approach to Evaluation of the Effect of Bioremediation on Biological Activity of Environmental Contaminants: Dechlorination of Polychlorinated Biphenyls Environmental Health Perspectives ·Patricia E. Ganey, Steven A. Boyd	2004	11
8	Selective Inhibition of ICAM-1 and E-Selectin Expression in Human Endothelial Cells. 2. Aryl Modifications of 4-(Aryloxy)thieno[2,3-c]pyridines with Fine-Tuning at C-2 Carbamides Journal of Medicinal Chemistry ·Gui‐Dong Zhu, David L. Arendsen, Indrani W. Gunawardana, Steven A. Boyd, Andrew O. Stewart, Dennis G. Fry, Barbara L. Cool, Lemma Kifle, Verlyn G. Schaefer, Joseph L. Meuth, Kennan C. Marsh, Anita J. Kempf-Grote, Patrick Kilgannon, W. Michael Gallatin, Gregory F. Okasinski	2001	46
9	Discovery of a series of pyrrolidine-based endothelin receptor antagonists with enhanced ETA receptor selectivity Bioorganic & Medicinal Chemistry ·Steven A. Boyd, Robert A. Mantei, Andrew S. Tasker, Gang Liu, Bryan K. Sorensen, Kenneth J. Henry, Thomas W von Geldern, Martin Winn, Jinshyun R. Wu‐Wong, William J. Chiou, Douglas B. Dixon, Charles W. Hutchins, Kennan C. Marsh, Bach Nguyen, Terry J. Opgenorth	1999	10
10	Pyrrolidine-3-carboxylic Acids as Endothelin Antagonists. 3. Discovery of a Potent, 2-Nonaryl, Highly Selective ET_A Antagonist (A-216546) Journal of Medicinal Chemistry ·Gang Liu, Kenneth J. Henry, Bruce G. Szczepankiewicz, Martin Winn, Guillermo Da Silva, Steven A. Boyd, James T. Wasicak, Thomas W von Geldern, Jinshyun R. Wu‐Wong, William J. Chiou, Douglas B. Dixon, Bach Nguyen, Kennan C. Marsh, Terry J. Opgenorth	1998	17
11	2,4-Diarylpyrrolidine-3-carboxylic AcidsPotent ET_A Selective Endothelin Receptor Antagonists. 1. Discovery of A-127722 Journal of Medicinal Chemistry ·Martin Winn, Thomas W von Geldern, Terry J. Opgenorth, Hwan-Soo Jae, Andrew S. Tasker, Steven A. Boyd, L. O. C. Silva, Robert A. Mantei, Naciye Ekiz, Bryan K. Sorensen, Jinshyun R. Wu‐Wong, William J. Chiou, Douglas B. Dixon, Eugene I. Novosad, Lisa E. Hernandez, Kennan C. Marsh	1996	98
12	Nonpeptide Renin Inhibitors with Good Intraduodenal Bioavailability and Efficacy in Dog Journal of Medicinal Chemistry ·Steven A. Boyd, Anthony K. L. Fung, William R. Baker, Robert A. Mantei, Herman H. Stein, Jerome D. Cohen, Saat Gusni, Vered Klinghofer, Jerry L. Wessale	1994	29
13	Synthesis and In Vitro evaluation of fused ring heterocyle-containing angiotensin II antagonists. Bioorganic & Medicinal Chemistry Letters ·Thomas M. Zydowsky, Martin Winn, Biswanath De, Irene Taccolini, Robert J. Altenbach, Fatima Z. Basha, Steven A. Boyd, Steven A. Buckner, Arthur A. Hancock, Jang Y. Lee, Robert A. Mantei, Eugene I. Novosad, Bryan K. Sorensen, Andrew S. Tasker, Kazumi Shiosaki, Daniel J. Kerkman, Terry J. Opgenorth, John F. DeBernardis	1994	5
14	Cardiovascular Effects and Hemodynamic Mechanism of Action of the Novel, Nonpeptidic Renin Inhibitor A-74273 in Dogs Journal of Cardiovascular Pharmacology ·Jerry L. Wessale, Samuel V. Calzadilla, Steven A. Boyd, William R. Baker, Herman H. Stein, Peter Kovar, Saat Gusni, Vered Klinghofer, Robert A. Mantei, Hollis D. Kleinert	1993	8
15	2-(Alkylamino)nicotinic acid and analogs. Potent angiotensin II antagonists Journal of Medicinal Chemistry ·Martin Winn, Biswanath De, Thomas M. Zydowsky, Robert J. Altenbach, Fatima Z. Basha, Steven A. Boyd, Michael E. Brune, Steven A. Buckner, Sujatha Peethala	1993	18
16	Effects of High Doses of A-74273, a Novel Nonpeptidic and Orally Bioavailable Renin Inhibitor Journal of Cardiovascular Pharmacology ·Kenneth M. Verburg, James S. Polakowski, Peter Kovar, Vered Klinghofer, Saat Gusni, Herman H. Stein, Robert A. Mantei, Anthony K. L. Fung, Steven A. Boyd, William R. Baker, Hollis D. Kleinert	1993	8
17	C-Terminal modifications of nonpeptide renin inhibitors: improved oral bioavailability via modification of physicochemical properties Journal of Medicinal Chemistry ·Steven A. Boyd, Anthony K. L. Fung, William R. Baker, Robert A. Mantei, Benjamin Richard Morris, Herman H. Stein, Jerome D. Cohen, David A. Egan, Saat Gusni	1992	27
18	Slow, tight binding to human renin of some nonpeptidic renin inhibitors containing a 4‐methoxymethoxypiperidinylamide at the P4 position FEBS Letters ·Herman H. Stein, Anthony K. L. Fung, Jerome Cohen, William R. Baker, Saul H. Rosenberg, Steven A. Boyd, Brian D. Dayton, Elvina Santana, Irene Taccolini, Robert A. Mantei, Hollis D. Kleinert	1992	9
19	Palladium-catalyzed synthesis of macrocycles. A total synthesis of (-)-aspochalasin B Journal of the American Chemical Society ·Barry M. Trost, Masayuki Ohmori, Steven A. Boyd, Md Habibullah, Steven J. Brickner	1989	45
20	Improved synthesis of conduritol B epoxide Carbohydrate Research ·Kevin J. Lee, Steven A. Boyd, Norman S. Radin	1985	26

About Steven A. Boyd

Steven A. Boyd is a scholar working on Biophysics, Endocrinology, Diabetes and Metabolism, Applied Microbiology and Biotechnology, Biochemistry and Molecular Medicine, having authored 34 papers that have together received 739 indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (8 papers), Receptor Mechanisms and Signaling (6 papers), Hormonal Regulation and Hypertension (5 papers), Nitric Oxide and Endothelin Effects (4 papers), Chemical Synthesis and Analysis (4 papers), Electron Spin Resonance Studies (4 papers), Synthetic Organic Chemistry Methods (4 papers) and Pancreatic function and diabetes (4 papers). The work is most often cited by research in Organic Chemistry (320 citations), Biochemistry (48 citations), Endocrinology, Diabetes and Metabolism (85 citations), Molecular Medicine (24 citations) and Molecular Biology (322 citations). Steven A. Boyd has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Robert A. Mantei, William R. Baker, Gui‐Dong Zhu, Kennan C. Marsh, Wayne J. Thompson, Martin Winn, Kevin J. Lee, Norman S. Radin, Barry M. Trost and Steven J. Brickner. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, The Journal of Organic Chemistry, Bioorganic & Medicinal Chemistry Letters and Journal of Cardiovascular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact